Announcing our new AI and machine learning partners

Announcing our new AI and machine learning partners

We are excited to share that Cures Within Reach for Cancer has launched collaborations with Innoplexus, IBM Research’s Science for Social Good Initiative, and Byron Wallace’s group at Northeastern University to build our Oncology Repurposing Engine™. ORE™ uses AI and machine learning to synthesize and prioritize data on non-cancer generic drugs being tested as cancer treatments.

Read More

Exploring how social impact bonds could fund drug repurposing clinical trials

Exploring how social impact bonds could fund drug repurposing clinical trials

By Monika Odermatt

Cures Within Reach for Cancer is developing innovative funding models and economic incentives to enable clinical testing of repurposed generic drugs for the treatment of cancer. I had the pleasure of speaking with Dr. Rick Thompson, CEO of Findacure in the UK, in October 2018. I had the opportunity to ask him about the drug repurposing social impact bond (SIB), the challenges he has encountered, and his perspective on the future of SIBs.

Read More